Related Experiment Video
Updated: Aug 31, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
P62/SQSTM1 mediates the autophagy-lysosome degradation of CDK2 protein undergoing PI3Kα/AKT T308 inhibition
Chao Zhang1, Hong-Liang Zhang2, Shan-Ling Liu3
1Department of Geriatrics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201999, China; Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, China.
Abstract:
CDK2 forms a complex with cyclin A and cyclin E to promote the progress of cell cycle, but when cyclin A and cyclin E are dissociated from the complex and degraded by the ubiquitin proteasome pathway, the fate of the inactive CDK2 is unclear. In this study, we found that the inactive CDK2 protein was degraded by autophagy-lysosome pathway. In the classic model of G0/G1 phase arrest induced by serum starvation, we found that the mRNA level in CDK2 did not change but the protein level decreased. Subsequently, using PI3K and AKT inhibitors and gene knockout methods, it was found that CDK2 degradation was mediated by the inhibition of PI3Kα/AKTT308. In addition, P62/SQSTM1 was found to bind to the inactivated CDK2 protein to help it enter autophagy-lysosome degradation in a CTSB-dependent manner. Taken together, these results confirm that the PI3Kα/AKTT308 inhibition leads to degradation of CDK2 protein in the autophagy-lysosome pathway. These data reveal a new molecular mechanism of CDK2 protein degradation and provide a new strategy and method for regulating CDK2 protein.
Insights
Inactive CDK2 protein is degraded via the autophagy-lysosome pathway, not the ubiquitin proteasome pathway. This degradation is mediated by PI3Kα/AKT inhibition and involves P62/SQSTM1 binding.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cyclin-dependent kinase 2 (CDK2) regulates cell cycle progression.
- The degradation pathway of inactive CDK2 after cyclin dissociation is not well understood.
- Existing knowledge focuses on the ubiquitin proteasome pathway for cyclin degradation.
Purpose of the Study:
- To elucidate the degradation mechanism of inactive CDK2 protein.
- To identify the specific pathway involved in CDK2 protein turnover.
- To explore novel regulatory strategies for CDK2 protein levels.
Main Methods:
- Serum starvation to induce G0/G1 phase arrest.
- Analysis of CDK2 mRNA and protein levels.
- Pharmacological inhibition of PI3K and AKT pathways.
- Gene knockout techniques.
- Immunoprecipitation to study protein interactions (P62/SQSTM1 binding).
Main Results:
- CDK2 protein levels decreased during serum starvation without changes in mRNA.
- CDK2 degradation was found to occur through the autophagy-lysosome pathway.
- Inhibition of PI3Kα/AKTT308 mediated CDK2 degradation.
- P62/SQSTM1 acts as an adaptor protein, binding to inactive CDK2 for autophagy-lysosome degradation in a CTSB-dependent manner.
Conclusions:
- Inactive CDK2 protein is degraded via the autophagy-lysosome pathway.
- The PI3Kα/AKTT308 signaling pathway plays a crucial role in regulating CDK2 degradation.
- This study reveals a novel mechanism for CDK2 protein regulation and suggests potential therapeutic targets.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
Abnormal Proliferation
Anaphase Promoting Complex
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle

